Loading...
The Pennant Group, Inc.
PNTG•NASDAQ
Healthcare
Medical - Care Facilities
$23.34
$0.23(1.02%)
The Pennant Group, Inc. (PNTG) Financial Performance & Income Statement Overview
Review The Pennant Group, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
27.59%
↑ 27.59%
Operating Income Growth
51.44%
↑ 51.44%
Net Income Growth
68.61%
↑ 68.61%
Operating Cash Flow Growth
18.76%
↑ 18.76%
Operating Margin
5.70%
↑ 5.70%
Gross Margin
13.27%
↑ 13.27%
Net Profit Margin
3.40%
↑ 3.40%
ROE
11.03%
↑ 11.03%
ROIC
6.50%
↑ 6.50%
The Pennant Group, Inc. (PNTG) Income Statement & Financial Overview
Review The Pennant Group, Inc.'s (PNTG) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $188.89M | $180.69M | $168.75M | $156.91M |
Cost of Revenue | $163.89M | $155.37M | $147.31M | $137.71M |
Gross Profit | $25.004M | $25.31M | $21.44M | $19.20M |
Gross Profit Ratio | $0.13 | $0.14 | $0.13 | $0.12 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $13.87M | $13.02M | $11.48M | $11.93M |
Operating Expenses | $15.77M | $14.52M | $11.48M | $11.93M |
Total Costs & Expenses | $179.66M | $169.89M | $158.78M | $149.64M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $650000.00 | $2.89M | $1.62M | $1.79M |
Depreciation & Amortization | $1.83M | $1.49M | $1.47M | $1.33M |
EBITDA | $11.08M | $12.40M | $11.03M | $9.10M |
EBITDA Ratio | $0.06 | $0.07 | $0.07 | $0.06 |
Operating Income | $9.24M | $10.79M | $9.96M | $7.28M |
Operating Income Ratio | $0.05 | $0.06 | $0.06 | $0.05 |
Other Income/Expenses (Net) | -$635000.00 | -$2.78M | -$1.62M | -$1.71M |
Income Before Tax | $8.60M | $8.01M | $7.94M | $6.82M |
Income Before Tax Ratio | $0.05 | $0.04 | $0.05 | $0.04 |
Income Tax Expense | $2.07M | $1.35M | $1.84M | $1.76M |
Net Income | $5.76M | $6.21M | $5.69M | $4.91M |
Net Income Ratio | $0.03 | $0.03 | $0.03 | $0.03 |
EPS | $0.17 | $0.20 | $0.19 | $0.16 |
Diluted EPS | $0.16 | $0.20 | $0.18 | $0.16 |
Weighted Avg Shares Outstanding | $34.27M | $30.28M | $30.14M | $30.05M |
Weighted Avg Shares Outstanding (Diluted) | $35.33M | $31.36M | $30.78M | $30.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan